Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
34.0%
% of FTXH's 51 holdings also in PBE
60.7%
% of PBE's 28 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 4.5% | 5.1% | 4.5% |
|
UNITED THERAPEUTICS CORP | 3.7% | 5.0% | 3.7% |
|
AMGEN INC | 3.1% | 4.7% | 3.1% |
|
BIOGEN IDEC INC | 2.8% | 4.8% | 2.8% |
|
REGENERON PHARMACEUTICALS | 2.4% | 4.9% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PBE
|
BRISTOL-MYERS SQUIBB CO | 8.7% |
|
JOHNSON & JOHNSON | 6.9% |
|
ABBVIE INC | 6.9% |
|
PFIZER INC | 6.8% |
|
MERCK & CO. INC. | 6.7% |
|
CARDINAL HEALTH INC | 4.1% |
|
VIATRIS, INC. | 4.1% |
|
ZOETIS INC | 3.8% |
 |
JAZZ PHARMACEUTICALS PLC | 3.5% |
|
ELI LILLY & CO | 3.2% |
FTXH Underweight Relative to PBE
|
NATERA INC | -5.1% |
|
ILLUMINA INC | -5.1% |
|
INCYTE CORP | -4.2% |
|
VERACYTE INC | -2.9% |
|
BIOCRYST PHARMACEUTICALS INC | -2.9% |
|
BIO-TECHNE CORPORATION | -2.8% |
|
CATALYST PHARMACEUTICAL PART | -2.8% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.7% |
|
CAREDX, INC. | -2.6% |
|
ROYALTY PHARMA PLC CLASS A | -2.6% |